Results 11 to 20 of about 25,773 (228)

Is the function of the HBeAg really unknown? [PDF]

open access: yesHuman Vaccines & Immunotherapeutics, 2019
The immune response to the hepatitis B virus (HBV) vaccine in newborns of hepatitis B e antigen (HBeAg)-positive or HBeAg-negative mothers is the subject of Huang et al. The authors report no correlation between the HBeAg status of the mothers/cord blood
David R. Milich
doaj   +4 more sources

Comparison of evolutionary patterns of different HBeAg status in HBV genotype B and C

open access: yesOpen Life Sciences, 2015
The aim of this work was to investigate the different evolutionary patterns between HBeAg(+) and HBeAg(-) status of genotype B and genotype C of Hepatitis B virus (HBV).
Cai Ying   +3 more
doaj   +2 more sources

Efficacy of a combination of HBV RNA and HBeAg in predicting HBeAg seroconversion in patients treated with entecavir for 144 weeks [PDF]

open access: yesInternational Journal of Infectious Diseases, 2020
Background: In some previous studies, serum hepatitis B virus RNA (HBV RNA) was proposed as an HBV viral marker during therapy. However, the dynamic change of HBV RNA, the correlation of HBV RNA with cccDNA, and the combination of HBV RNA with known HBV ...
Xiaomei Wang   +24 more
doaj   +3 more sources

Cost-Effectiveness and Clinical Impact of Antiviral Strategies of HBeAg-Positive and -Negative Chronic Hepatitis B

open access: yesAnnals of Hepatology, 2017
Introduction: Chronic hepatitis B (CHB) is associated with high burden and healthcare costs. Virologic response achieved with an-tivirals is associated with progression avoidance.
Itziar Oyagüez   +4 more
doaj   +2 more sources

A novel nomogram for predicting HBeAg seroclearance in HBeAg-positive chronic hepatitis B patients treated with nucleos(t)ide analogues

open access: yesAnnals of Hepatology
Introduction and Objectives: Seroclearance of hepatitis B e antigen (HBeAg) is an important treatment goal for patients with chronic hepatitis B (CHB).
Yan Gu   +13 more
doaj   +2 more sources

The Safety, Pharmacokinetics, and Antiviral Activity of ABI-4334, A Novel Next-Generation Hepatitis B Capsid Assembly Modulator. [PDF]

open access: yesJ Viral Hepat
ABSTRACT Novel, well‐tolerated, short‐term therapeutics for chronic hepatitis B virus infection (cHBV) are needed. ABI‐4334 is a next‐generation capsid assembly modulator that targets the HBV core protein. The safety, tolerability, and pharmacokinetics of ABI‐4334 in healthy volunteers and participants with cHBV and antiviral effects in participants ...
Gane EJ   +11 more
europepmc   +2 more sources

Virological significance of HBeAg subtypes (HBeAg/1 and HBeAg/2) in patients with type B hepatitis

open access: yesHepatology, 1987
In order to establish the virological significance of HBeAg subtypes (HBeAg/1 and HBeAg/2) during hepatitis B virus infection, HBsAg, HBeAg and hepatitis B virus DNA in serum and HBeAg in liver were determined quantitatively in relation to the detection of HBeAg subtypes in agar gel diffusion.
A, Kanno   +8 more
  +7 more sources

Mitochondrial stress in advanced fibrosis and cirrhosis associated with chronic hepatitis B, chronic hepatitis C, or nonalcoholic steatohepatitis

open access: yesHepatology, EarlyView., 2022
Adaptive mitochondrial mechanisms allow mitochondrial resilience and prevent the worsening of fibrosis, while deregulation of these mechanisms promotes the progression from no/minimal‐mild (F0‐F2) fibrosis to advanced fibrosis and cirrhosis (F3‐F4). Abstract Background and Aims Hepatitis B virus (HBV) infection causes oxidative stress (OS) and alters ...
Dimitri Loureiro   +17 more
wiley   +1 more source

Anti-Viral Treatment Eligibility and Treatment Uptake Among People With Chronic Hepatitis B in Australia: The REACH-B Study. [PDF]

open access: yesJ Viral Hepat
ABSTRACT Treatment indication for chronic hepatitis B (CHB) varies across clinical guidelines. This study evaluated treatment eligibility and uptake in a large Australian cohort of people with CHB. The REACH‐B study recruited people with CHB managed through a national network of healthcare services.
Hajarizadeh B   +28 more
europepmc   +2 more sources

Mathematical investigation of HBeAg seroclearance

open access: yesMathematical Biosciences and Engineering, 2019
Spontaneous or drug-induced loss of hepatitis B e antigen is considered a beneficial event in the disease progression of chronic hepatitis B virus infections. Mathematical models of within-host interactions are proposed; which provide insight into hepatitis B e antibody formation, its influence on hepatitis B e antigen seroclearance, and reversion of ...
Sarah Kadelka, Stanca M Ciupe
openaire   +4 more sources

Home - About - Disclaimer - Privacy